Tamoxifen effect on L-DOPA induced response complications in parkinsonian rats and primates.
Smith, C P S
Tamoxifen effect on L-DOPA induced response complications in parkinsonian rats and primates. [electronic resource] - Neuropharmacology Feb 2007 - 515-26 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Intramural
0028-3908
10.1016/j.neuropharm.2006.08.018 doi
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Animals
Antiparkinson Agents--adverse effects
Disease Models, Animal
Drug Administration Schedule
Drug Interactions
Dyskinesia, Drug-Induced--drug therapy
Haplorhini
Levodopa--adverse effects
Male
Models, Biological
Nerve Tissue Proteins--metabolism
Oxidopamine
Parkinson Disease, Secondary--chemically induced
Protein Kinase C--metabolism
Rats
Rats, Sprague-Dawley
Selective Estrogen Receptor Modulators--therapeutic use
Tamoxifen--therapeutic use
Time Factors
Tamoxifen effect on L-DOPA induced response complications in parkinsonian rats and primates. [electronic resource] - Neuropharmacology Feb 2007 - 515-26 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Intramural
0028-3908
10.1016/j.neuropharm.2006.08.018 doi
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Animals
Antiparkinson Agents--adverse effects
Disease Models, Animal
Drug Administration Schedule
Drug Interactions
Dyskinesia, Drug-Induced--drug therapy
Haplorhini
Levodopa--adverse effects
Male
Models, Biological
Nerve Tissue Proteins--metabolism
Oxidopamine
Parkinson Disease, Secondary--chemically induced
Protein Kinase C--metabolism
Rats
Rats, Sprague-Dawley
Selective Estrogen Receptor Modulators--therapeutic use
Tamoxifen--therapeutic use
Time Factors